Open Access

Phenotype of apoptotic lymphocytes in children with Down syndrome

Immunity & Ageing20096:2

https://doi.org/10.1186/1742-4933-6-2

Received: 26 November 2008

Accepted: 06 March 2009

Published: 06 March 2009

Abstract

Background

Down syndrome (DS) is the most common and best-known chromosomal disorder and is associated with several other pathologic conditions including immunodeficiency which makes a significant contribution to morbidity and mortality. Various immunological theories and observations to explain the predisposition of individuals with DS to various infections have been published, one of which is increased apoptotic cells.

Aim

The aim of this study was to identify the effect of apoptosis on both types of cells of specific immune response (T and B lymphocytes) in children with DS using Annexin V staining of phosphatidyserine (PS) as a specific marker of early apoptosis.

Subjects and methods

The study included 17 children with karyotypically ascertained DS (7 males and 10 females). Their ages ranged from 4 months to 14 years with mean age of 5.7 ± 4.35 years. Seventeen age and sex matched healthy children were included in the study as controls. Patients or controls with infections were excluded from the study. Complete blood picture, immunophenotyping, analysis of apoptosis using Annexin V was done at National cancer Institute to all children included in this study.

Results

Although CBC, differential count, relative and absolute number of CD3+ and CD16+ did not show significant differences between DS children and control group, the relative and the absolute size of apoptotic CD3+ T lymphocytes, and the relative size of apoptotic CD19+ B lymphocytes were significantly higher in DS children than in controls. On the other hand, no significant difference was detected as regards the absolute size of CD19+ B lymphocytes in DS children and in controls

Conclusion

our finding of increased early apoptotic cells (especially T cells) in DS children may emphasize the fact that the function of cells- and not their number- is main mechanism responsible for the impairment of the immune system in DS children and may further add to the known fact that cellular immunity is more severely affected than humoral immunity in these children. Further studies on apoptotic cellular phenotype in larger number of DS are needed

Introduction

Down syndrome (DS) is the most common and best-known chromosomal disorder. It is associated with several pathologic conditions including immunodeficiency which makes a significant contribution to morbidity and mortality in these children. Various immunological theories and observations to explain the predisposition of individuals with DS to infections have been published [16]. One of the most interesting; is the "precocious aging" theory in which increased apoptosis is the main cornerstone [7]. Previous authors reported increased apoptotic cells in neurons and granulocytes of DS patients [8, 9]. It has also been studied in the peripheral blood by means of electron microcopy, in situ nick translation (ISNT) and DNA electrophoresis [10]. These methods detects only late events of apoptosis (apoptotic body formation and fragmentation of DNA into oligonucleosomal fragments). Early apoptosis can be detected using Annexin V staining of phosphatidyserine (PS). This method has been used before by Corsi et al., 2003 who reported an increase in early apoptotic CD3 lymphocytes in DS children compared to the controls [11]. However, the effect of apoptosis on both types of cells of specific immune response (T and B lymphocytes) was not studied before.

The aim of this study was to identify the effect of apoptosis on both types of cells of specific immune response (T and B lymphocytes) in children with DS using Annexin V staining of phosphatidyserine (PS) as a specific marker of early apoptosis.

Subjects and methods

Subjects

The study included 17 children with karyotypically ascertained DS (7 males and 10 females) from the genetics clinic, Ain Shams University. Their ages ranged from 4 months to 14 years with mean age of 5.7 years ± 4.3 years and a median of 7 years. Seventeen age and sex matched healthy children were included in the study as controls. Each patient had a karyotypically normal control from the same age and sex (controls were actually healthy patients' sibs to stabilize diet and other environmental factors that may affect immunity). Patients or controls with respiratory, urinary tract, gastrointestinal or other infections were excluded from the study. Complete blood picture and analysis of apoptosis were done in the National cancer Institute to all children included in this study.

Methods

1-Complete blood count and immunophenotyping

The relative and the absolute leukocyte counts were determined with a Sysmex SE-9500 hematology analyzer (Sysmex, Kobe, Japan). The region of lymphocyte population (lymphocyte gate), was set manually, based on the forward-scatter and side-scatter characteristics (Beckman Coulter flow cytometer, USA). The relative count of each lymphocyte subpopulation was expressed as a percentage within the total lymphocyte population. The absolute count of each lymphocyte subpopulation (CD3+ and CD19+ lymphocytes) was calculated from the relative count of the lymphocyte subpopulation, the relative count of the total lymphocyte population, and the absolute leukocyte count [12].

2-Apoptosis in peripheral T- and B-lymphocytes

During apoptosis, externalization of phosphatidyserine (PS) and phosphatidylethanolamine is a hallmark of the changes in the cell surface. These phospholipids are normally sequestered within the cell surface on the cytoplasmic side of the plasma membrane. This occurs relatively early just after segmentation of the nucleus during which the cell membrane remains intact [13].

The permeability of the plasma membrane is a central difference between necrosis and apoptosis. Large molecular DNA binding dyes, such as propidium iodide (PI), can not enter intact cells because of their large size and without permebilization treatment, and do not label apoptotic cells until the final lysis stage. Annexin V, a Ca2-dependent phospholipids binding protein, which possesses high affinity for PS can be used specifically for detecting early apoptotic cells. When used with promidium iodide (PI), Annexin V staining allows the quantification of cells at early stages of apoptosis and the simultaneous identification of cell surface markers [14].

In this study, apoptosis in T- and B-lymphocytes was measured by staining with Fluorescein isothiocyanate (FITC) conjugated annexin V, and Propidium iodide (PI) using IQ products Phosphatidyl Serine Detection Kit (IQP-116F). Indotricarbocyanine (Cy5) coupled to Phycoerythrin (PE) conjugated anti-CD3 (PE-Cy5) IQP-519 and anti-CD19 (PE-Cy5) Dako-C7066 antibodies were used to identify apoptotic cell phenotype. Three-color flow cytometry analysis was performed on a BCKMAN Coulter equipped with a single 488 nm argon ion laser. At least 10,000 events were acquired for each sample. The voltages and compensation were set according to the standard procedure, using negative controls and tested cells stained in a single color or a combination of colors. The proportion of FITC+/PI-, corresponding to early apoptosis in T and B lymphocytes, was evaluated by gating for CD3-PE-Cy5 and CD19-PE-Cy5.

Results

1-Complete blood picture (CBC) and differential count

Red blood cells, count, haemoglobin level, heamatocrite level, mean corpuscular volume, mean corpuscular heamoglobin, platelets and total leucocytic counts did not show significant difference between DS children and control group. No significant difference was also observed between the percentage and the absolute values of neutrophils, lymphocytes, monocytes or eosinophils between DS and normal children. The percentage of basophils was significantly higher in DS children but no significant difference was detected when absolute values were compared.

2-Lymphocyte population

Neither the absolute nor the relative values for CD3+ T lymphocytes and CD19+ B lymphocytes showed a significant difference between children with DS and controls. A slight lower figure was noted in absolute value of CD19+ B lymphocytes in DS children (table 1).
Table 1

Lymphocyte population in DS children and controls

Variable

DS

(Mean ± SD)

Controls

(Mean ± SD)

P-value

CD 3+ T lymphocytes

Percentage

67.19 ± 11.81

62.11 ± 10.31

0.163

 

Absolute (×10 3 /μl)

2.44 ± 3.05

2.16 ± 1.17

0.687

CD 19+ B lymphocytes

Percentage

13.20 ± 5.74

17.39 ± 7.27

0.136

 

Absolute (×10 3 /μl)

0.40 ± 0.31

0.67 ± 0.61

0.076

3-Early apoptosis in peripheral blood T and B lymphocytes

• CD3+ T lymphocytes: Both relative and the absolute size of early apoptotic CD3+ T lymphocytes, were significantly higher in DS children than in controls.

• CD19+ B lymphocytes: The relative size of early apoptotic CD19+ B lymphocytes were significantly higher in DS children than in controls, however, the absolute size was insignificantly higher in DS children compared to the controls, (table 2) and (figure 1, figure 2)

Figure 1

Flow cytometric analysis of apoptotic CD 3+ T-lymphocytes in a healthy control. From left to right: 1-dot plot showing gating on total lymphocytes, 2-dot plot showing gating on CD3+ T-lymphocytes, 3-dot plot showing the proportion of early apoptotic cells in the upper left quadrant.

Figure 2

Flow cytometric analysis of apoptotic CD 3+ positive T-lymphocytes in a child with Down syndrome. The percentage of FITC+/PI-in the upper left quadrant (early apoptotic cells), and the FITC+/PI+ in the upper right quadrant (late apoptotic cells) as well as the FITC-/PI+ (necrotic) cells in the lower right quadrant after gating on CD3+ cells in a DS child.

Table 2

Early apoptosis in peripheral blood T- and B – lymphocytes in DS children and controls.

 

Variable

DS

(Mean ± SD)

Controls

(Mean ± SD)

P-value

CD3

Percentage

32.11 ± 13.57

9.65 ± 8.04

0.001

 

Absolute (×10> 3 /μl)

0.79 ± 1.19

0.18 ± 0.13

0.001

CD19

Percentage

27.85 ± 16.68

13.54 ± 12.36

0.022

 

Absolute (×10 3 /μl)

0.10 ± 0.07

0.08 ± 0.11

0.286

Discussion

An impairment of both specific and non-specific immunity has been documented in patients with DS. Decreased neutrophil chemotaxis, leucocytes opsonization, and phagocytosis and leucocytes bactericidal activity were described in children with DS [15].

Several studies have focused their attention on the role of the thymus, and have described a variety of structural and anatomic alterations present in DS [16]. Studies of T-cell phenotype and function have frequently resulted in conflicting results, the overall evidence strongly pointed to a primary and profound impairment of T-cell mediated immunity [17].

In this work, neither the absolute nor the relative values for CD3+ T lymphocytes and CD19+ B lymphocytes showed a significant difference between children with DS and controls. Previous quantitative studies of peripheral blood T lymphocytes revealed a reduction, often quite small, in the percentage and/or absolute number of T lymphocytes, although normal proportions or numbers of T and B lymphocytes in DS children have also been reported [1, 11].

Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development during embryogenesis as well as in adult tissues during cell turn-over. It was suggested that apoptosis provides the mechanism for deletion of auto reactive T-cells in the thymus, low responsive B-cells in the germinal center, and of target cells attacked by cytotoxic T-lymphocytes and natural killer cells [13].

Previous studies evaluated apoptosis in peripheral blood of patients with DS by different methods but did not identify the phenotype of apoptotic cells [10]. In our work, both relative and absolute number of early apoptotic T cells (CD3+ annexinV positive cells), were significantly lower in DS children while the absolute number of T-lymphocytes was insignificantly different. In other words, the function and not the number of T lymphocytes is the main mechanism responsible for the impairment of immunity in these children. This result supports the finding of Corsi et al., 2003 who explained this increase in apoptotic T cells by antigen overload combined with impairment of nutrient absorption (like zinc) secondary to altered function of the gastrointestinal mucosa [11]. Actually, decrease in number of apoptotic cells was observed after zinc supplementation in these children [10].

In our study, although both T and B cells showed increased apoptosis, B cells were less functionally impaired (as their absolute number was insignificantly different), which agrees with previous studies reporting that humoral immunity is less-strikingly impaired in these children [17] and necessitates further study on a larger scale of DS population to confirm this finding.

On the other hand, Roat et al., 2007 found that DS peripheral blood mononuclear cells (PBMNC) with altered mitochondrial function do not undergo apoptosis, and hypothesized that DS patients tend to maintain damaged cells, or that they have a higher capacity to repair functional damages. They added that it remains to be established if and how this phenomenon can be linked to the development of autoimmunity or neoplastic disorders. In contrast to their study, we studied only lymphocytes and not all PBMNC and that may explain the difference between the two studies [18].

Other authors implicate the absence of early expansion of T and B-lymphocytes in the peripheral blood of children with DS in the first year of life as the main cause of recurrent infections in early life of these children. They found also that T-lymphocyte subpopulation gradually approaches those of normal children over time which contradicts the theory of precocious aging. Nevertheless it does not explain the observed disturbance in the adaptive immune system in DS after the first year [12].

In conclusion, our finding of increased early apoptotic cells (especially T cells) in DS children may emphasize the fact that the function of cells- and not their number- is main mechanism responsible for the impairment of the immune system in DS children and may further add to the known fact that cellular immunity is more severely affected than humorral immunity in these children. Further studies on apoptotic cellular phenotype in larger number of DS are needed.

Abbreviations

Cy5: 

Indotricarbocyanine

DS: 

Down syndrome

FITC: 

Fluorescein isothiocyanate

ISNT: 

in situ nick translation

PI: 

Propidium iodide

PBMNC: 

Peripheral blood mononuclear cells

PE: 

Phycoerythrin

PS: 

phosphatidyserine.

Declarations

Authors’ Affiliations

(1)
Genetics Unit, Pediatrics Department, Ain Shams University
(2)
Clinical Pathology Department, National Cancer Institute, Cairo University

References

  1. Cuadrado E, Barrena MJ: Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?. Clin Immunol Immunopathol. 1996, 78: 209-14. 10.1006/clin.1996.0031.View ArticlePubMedGoogle Scholar
  2. Nespoli L, Burgio GR, Ugazio AG, Maccario R: Immunological features of Down's syndrome: a review. J Intellect Disabil Res. 1993, 37: 543-51.View ArticlePubMedGoogle Scholar
  3. Cossariza A, Monti D, Montanani G, Ortolani C, Masi M, Zannoti M, Franceschi C: Precocious aging of the immune system in Down syndrome: alteration of B-lymphocyte, T lymphocytes subsets, and cells with natural killer markers. Am J Med Genet Suppl. 1990, 7: 213-8. 10.1002/ajmg.1320370743.Google Scholar
  4. Licastro F, Melotti C, Parente R, Davis LJ, Chiricolo M, Zannoti M, Barboni F: Derangement of non-specific immunity in Down syndrome subjects: low leukocyte chemiluminescence activity after phagocytic activation. Am J Med Genet Suppl. 1990, 7: 242-6. 10.1002/ajmg.1320370749.PubMedGoogle Scholar
  5. Loh RK, Harth SC, Thong YH, Ferrante A: Immunoglobulin G subclass deficiency and predisposition to infection in Down's syndrome. Pediatr Infect Dis J. 1990, 9: 547-51.View ArticlePubMedGoogle Scholar
  6. Lockitch G, Singh VK, Puterman ML, Godolphin WJ, Sheps S, Tingle AJ: Age related changes in humoral and cell mediated immunity in Down syndrome children living at home. Pediatr Res. 1987, 22: 536-40. 10.1203/00006450-198711000-00013.View ArticlePubMedGoogle Scholar
  7. Martin GM: genetic syndromes in man with potential relevance to the pathophysiology of ging. Genetic effects of aging. Birth defects. Edited by: Bergsma D, Harrison DE. 1978, New York, NY, Liss, for the National foundation-March of Dimes, 14: 5-Google Scholar
  8. Busciglio J, Yankner BA: Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature. 1995, 378: 776-9. 10.1038/378776a0.View ArticlePubMedGoogle Scholar
  9. Yasui K, Shinozaki K, Nakazwa T, Agemastu K, Komiyama A: Presenility of granulocytes in Down syndrome individuals. Am J Med Genet. 1999, 84: 406-12. 10.1002/(SICI)1096-8628(19990611)84:5<406::AID-AJMG4>3.0.CO;2-4.View ArticlePubMedGoogle Scholar
  10. Antonucci A, Baldassarre A, Franco DG, Stuppia L, Palka G: Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy. Ultrastructural pathology. 1997, 21: 449-52. 10.3109/01913129709021944.View ArticlePubMedGoogle Scholar
  11. Corsi MM, Ponti W, Venditti A, Ferrara F, Baldo C, Chiappelli M, Licastro F: Proapoptotic activated T-cells in the blood of children with Down syndrome: Relationship with dietary antigens and intestinal alterations. Int J Tissue React. 2003, 25: 117-25.PubMedGoogle Scholar
  12. De Hingh YC, Vossen VD, Gemen EF, Mulder AB, Hop WCJ, Brus F, Vries ED: Intrensic abnormalities of lymphocyte counts in children with Down syndrome. J pediatr. 2005, 147: 744-7. 10.1016/j.jpeds.2005.07.022.View ArticlePubMedGoogle Scholar
  13. Koopamn G, Reutelingsper CPM, Kuijten GAM, Keehnen RMJ, Pals ST, Vanores MHJ: Annexin V for flow cytometric detection of phosphatedylserine expression on B cells undergoing apoptosis. Blood. 1994, 84: 1415-20.Google Scholar
  14. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay of apoptosis. Flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J immunol Methods. 1995, 184: 39-51. 10.1016/0022-1759(95)00072-I.View ArticlePubMedGoogle Scholar
  15. Licastro F, Chiricolo M, Mocchegiani E, Fabris N, Zannoti M, Beltrandi E, Mancini R, Parente R, Arena G, Masi M: Oral zinc supplementation in Down's syndrome subjects decreased infections and normalized some humoral and cellular immune parameters. J Intellect Disabil Res. 1994, 38: 149-62.View ArticlePubMedGoogle Scholar
  16. Larocca LM, Piantelli M, Valitutti S, Castellino F, Maggiano N, Musiani P: Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21). Clin Immunol Immunopathol. 1988, 49: 175-86. 10.1016/0090-1229(88)90108-0.View ArticlePubMedGoogle Scholar
  17. Ugazio AG, Maccario R, Notaangelo LD, Burgio GR: Immunology of Down syndrome; A review. Am J Med Genet. 1990, 204-12. 10.1002/ajmg.1320370742. SupplGoogle Scholar
  18. Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, Nemes E, Lugli E, Biagioni O, Mariotti M, Ciacci L, Consolo U, Balli F, Cossarizza A: Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 2007, 581: 521-5. 10.1016/j.febslet.2006.12.058.View ArticlePubMedGoogle Scholar

Copyright

© Elsayed and Elsayed; licensee BioMed Central Ltd. 2009

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.